首页 News 正文

On November 30th local time, Novo Nordisk USA announced that as part of its ongoing commitment to patient safety, the company is taking several additional legal actions to protect American patients and consumers from adulterated drugs claimed to contain semaglutide sold by two pharmacies, Wells Pharmaceuticals and Brooksville Pharmaceuticals.
您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

六月清晨搅 注册会员
  • 粉丝

    0

  • 关注

    0

  • 主题

    30